Paper41575474
BMP7 attenuates myocardial injury and preserves cardiac function after myocardial infarction by inhibiting cardiomyocyte pyroptosis.
Liu M and 5 others. Apoptosis, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. BMP7 attenuates myocardial injury and preserves cardiac function after myocardial infarction by inhibiting cardiomyocyte pyroptosis. Papers, record 41575474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41575474
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BMP7 attenuates myocardial injury and preserves cardiac function after myocardial infarction by inhibiting cardiomyocyte pyroptosis.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Morphogenetic Protein 7 | Major topic |
| Myocardial Infarction | Major topic |
| Pyroptosis | Major topic |
| Myocytes, Cardiac | Major topic |
| Animals | |
| Humans | |
| Rats | |
| Mice | |
| Male | |
| NLR Family, Pyrin Domain-Containing 3 Protein | |
| Fibrosis | |
| Myocardium | |
| Disease Models, Animal | |
| Mice, Inbred C57BL | |
| Inflammasomes | |
| Rats, Sprague-Dawley |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82370467 | National Natural Science Foundation of China | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27502078 | Acute myocardial infarction. | Lancet | 2017 | https://conductscience.org/library/papers/27502078 | PubMed |
| 2 | 39928355 | Prognosis following acute myocardial infarction. | Eur Heart J | 2025 | https://conductscience.org/library/papers/39928355 | PubMed |
| 3 | 38150879 | Metabolic signatures in post-myocardial infarction heart failure, including insights into prediction, intervention, and prognosis. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38150879 | PubMed |
| 4 | 35972638 | Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction. | Curr Cardiol Rep | 2022 | https://conductscience.org/library/papers/35972638 | PubMed |
| 5 | 29496021 | Post-Myocardial Infarction Heart Failure. | JACC Heart Fail | 2018 | https://conductscience.org/library/papers/29496021 | PubMed |
| 6 | 25775052 | Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. | JAMA | 2015 | https://conductscience.org/library/papers/25775052 | PubMed |
| 7 | 35511857 | Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. | Eur Heart J | 2022 | https://conductscience.org/library/papers/35511857 | PubMed |
| 8 | 39833636 | Programmed cardiomyocyte death in myocardial infarction. | Apoptosis | 2025 | https://conductscience.org/library/papers/39833636 | PubMed |
| 9 | 37923829 | The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. | Nat Rev Cardiol | 2024 | https://conductscience.org/library/papers/37923829 | PubMed |
| 10 | 33776057 | Pyroptosis: mechanisms and diseases. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33776057 | PubMed |
| 11 | 32109412 | Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis. | Cell | 2020 | https://conductscience.org/library/papers/32109412 | PubMed |
| 12 | 34589396 | Gasdermin D in pyroptosis. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/34589396 | PubMed |
| 13 | 35868567 | Current knowledge of pyroptosis in heart diseases. | J Mol Cell Cardiol | 2022 | https://conductscience.org/library/papers/35868567 | PubMed |
| 14 | 38461908 | Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications. | Eur J Pharmacol | 2024 | https://conductscience.org/library/papers/38461908 | PubMed |
| 15 | 38645692 | Exploring the role of pyroptosis in the pathogenicity of heart disease. | Front Physiol | 2024 | https://conductscience.org/library/papers/38645692 | PubMed |
| 16 | 34015941 | GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury. | Circ Res | 2021 | https://conductscience.org/library/papers/34015941 | PubMed |
| 17 | 34531373 | Pyroptosis inhibition improves the symptom of acute myocardial infarction. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34531373 | PubMed |
| 18 | 38124338 | Bone morphogenetic protein signaling: the pathway and its regulation. | Genetics | 2024 | https://conductscience.org/library/papers/38124338 | PubMed |
| 19 | 30246251 | Bone morphogenetic protein receptor signal transduction in human disease. | J Pathol | 2019 | https://conductscience.org/library/papers/30246251 | PubMed |
| 20 | 36909186 | Insights into bone morphogenetic proteins in cardiovascular diseases. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36909186 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948070 | Pyroptosis in myocardial ischemia-reperfusion injury: mechanistic pathways and therapeutic prospects. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42948070 | PubMed |
| 42656742 | Targeting efferocytosis with carbonized polymer dots from a natural anti-inflammatory drug to alleviate excessive inflammatory responses in the acute phase of myocardial infarction. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42656742 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BMP7 | 655 | PubTator's text mining | https://conductscience.org/library/genes/655 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| RELA | 5970 | PubTator's text mining | https://conductscience.org/library/genes/5970 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41575474
GET https://conductscience.org/api/papers/v1/41575474/references?page=2